International Journal of Internal Medicine. 2020; 1: (1) 3; DOI:10.26855/j.ijim.20200003.
Objective: To analyze the effect of intracranial vascular interventional therapy in the treatment of ischemic cerebrovascular disease, in order to provide some help for medical staff to carry out their work. Methods: In this experiment, 70 patients with ischemic cerebrovascular disease in our hospital were selected from August 2018 to August 2019. The patients were divided into two groups of A and B by drawing lots, and the patients in the two groups were the same. Medical staff performed routine treatment for patients in group A, and intracranial vascular interventional treatment for patients in group B. Statistics and records of the occurrence of transient cerebral ischemia, cerebral infarction, and NIHSS scores were performed in both groups. Results: The results of the study showed that compared with patients in group A, the incidence of transient cerebral ischemia was lower in group B. The incidence of transient cerebral ischemia in the two groups was 8.57% and 0.00%, respectively. The difference was statistically significant (p <0.05). The incidence of cerebral infarction in group B was significantly lower than that in group A. The incidence of cerebral infarction (one year) in the two groups was 17.14% and 2.86%, respectively. The difference between the two groups Significant and statistically significant (p <0.05). After treatment, compared with group A, patients in group B had lower NIHSS scores. The two groups had NIHSS scores of (8.22 ± 1.36) points and (8.22 ± 1.36) points. The differences between the groups were significant and statistically significant (p <0.05). Before treatment, the NIHSS scores of patients in group A and group B were (10.97 ± 1.31) points and (10.98 ± 1.30) respectively. There was no significant difference in the NIHSS scores of patients in group A and group B, and there was no statistical significance (p> 0.05). Conclusion : Intracranial vascular interventional therapy has a good effect in the treatment of ischemic cerebrovascular disease. It can reduce the transient cerebral ischemia and cerebral infarction in patients with ischemic cerebrovascular disease to a certain extent, and reduce the The NIHSS score has certain practical significance.